←
Third Rock Ventures374 posts
Third Rock Ventures avatar

Third Rock Ventures

@ThirdRockV
◷ Joined March 2016▧ 157 Photos and videos
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·12 Nov 2024

Congratulations to @TraceNeuro on their launch with a $101M Series A! We are excited to support a team on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases.

1 in 400 people around the world will be diagnosed w/ #ALS in their lifetime. Meet Trace - on a mission to expand the promise of genomic medicine for those w/ neurodegenerative diseases, re-establishing healthy communication between nerves & muscle cells. businesswire.com/news/home/2…

1:35
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·19 Aug 2024

Congrats to the @moma_tx team! One step closer to helping oncology patients.

The 1st patient has been dosed in the Phase 1 clinical trial of MOMA-313, a novel, highly potent & selective oral POLq helicase inhibitor, & we've selected our 2nd development candidate, MOMA-341, an oral Werner helicase inhibitor. Read & learn more: businesswire.com/news/home/2…

1:24
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·15 Aug 2024

We are excited by @AbataTx announcement today of a strategic investment from @bmsnews supporting advancement of its Treg cell therapies into clinical development. One step closer to positively impacting patients and their families.

This tweet is unavailable

Life Science Cares avatar
⟳ Third Rock Ventures retweeted
Life Science Cares@LS_Cares·13 Dec 2023

And we’re live! Check out the very first episode of our new podcast: Moving Forward, Giving Back. On today’s show, we highlight our 2023 Impact Award Winners - exploring the ways they use the LSC model to support their communities. Tune in here: lifesciencecares.org/podcast…!

Post attachment
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·8 Dec 2023

Congrats to the team at @bluebirdbio ! Exciting news for patients and their families

#NewsfromtheNest: We are thrilled to announce that the @US_FDA has approved our first gene therapy for patients ages 12 and older living with sickle cell disease who have a history of vaso-occlusive events. Read more in our press release: investor.bluebirdbio.com/new… [1/1]

1:13
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·17 Aug 2023

Our collaboration with BrightEdge broadens the impact we can have across the oncology ecosystem. You can learn more about the great work they do below.

BrightEdge is poised to impact the lives of over 1.5 million cancer patients through investments in cancer-focused therapies and technologies. To learn more, read the annual report: cancer.org/brightedge

0:42
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·13 Jun 2023

We had the pleasure of hosting an inspiring fireside chat with @TracyDixonSalaz and Brad Galer about rare epilepsies and Lennox-Gastaut Syndrome and the high unmet medical need in the precision neuromedicine space.

Post attachment
Third Rock Ventures avatar
Third Rock Ventures@ThirdRockV·1 Jun 2023

Please join us in welcoming Mary Lynne Hedley to TRV as our newest Venture Partner. She brings valuable leadership and strategic insight across R&D, operations, corporate strategy and business development. We are excited to have her as part of the team!

Post attachment